Related Experiment Video
Updated: Aug 5, 2025
11:43
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
10.6K
Targeting Glutamine Metabolism in Prostate Cancer
Neil Bhowmick1, Edwin Posadas1, Leigh Ellis1
1Department of Medicine, Division of Hematology and Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Frontiers in Bioscience (Elite Edition)
|March 23, 2023
Summary
Prostate cancer cells rely on glutamine metabolism for growth. Targeting this pathway, particularly with glutaminase inhibitors, shows therapeutic promise for managing prostate cancer progression.
Area of Science:
- Biochemistry
- Oncology
- Metabolic pathways
Background:
- Glutamine is crucial for cancer cell proliferation, supporting nucleotide synthesis, redox balance, and energy production.
- Prostate cancer exhibits a significant dependency on glutamine for tumor growth and survival.
- Tumor microenvironment factors can enhance glutamine signaling, promoting prostate cancer progression.
Purpose of the Study:
- To review preclinical evidence linking glutamine metabolism to prostate cancer progression.
- To examine the regulation of glutamine metabolism by key pathways in prostate cancer.
- To discuss the therapeutic potential of targeting glutamine metabolism in prostate cancer.
Main Methods:
- Review of preclinical studies on glutamine metabolism in prostate cancer.
- Analysis of regulatory pathways including androgen receptor, MYC, and PTEN/PI3K/mTOR.
- Discussion of therapeutic strategies and clinical trial data for glutaminase inhibitors.
Main Results:
- Preclinical data strongly support the role of glutamine metabolism in prostate cancer progression.
- Androgen receptor, MYC, and PTEN/PI3K/mTOR pathways significantly regulate glutamine metabolism in prostate cancer.
- Selective glutaminase inhibitors demonstrate safety and tolerability in early-phase clinical trials.
Conclusions:
- Targeting glutamine metabolism represents a viable therapeutic strategy for prostate cancer.
- Understanding tumor metabolism and the tumor microenvironment is key to successful therapeutic translation.
- Glutaminase inhibitors offer a promising avenue for prostate cancer treatment.
